- $14.68bn
- $13.86bn
- $2.68bn
- 94
- 17
- 81
- 69
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,295 | 3,121 | 3,703 | 3,155 | 2,676 |
Cost of Revenue | |||||
Gross Profit | 1,340 | 1,786 | 2,207 | 1,867 | 1,537 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,741 | 2,193 | 2,531 | 2,323 | 2,175 |
Operating Profit | 554 | 928 | 1,172 | 832 | 501 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 526 | 901 | 1,161 | 840 | 526 |
Provision for Income Taxes | |||||
Net Income After Taxes | 467 | 784 | 1,015 | 716 | 449 |
Net Income Before Extraordinary Items | |||||
Net Income | 467 | 784 | 1,015 | 716 | 449 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 467 | 784 | 1,015 | 716 | 449 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.55 | 4.22 | 5.71 | 4.3 | 2.84 |
Dividends per Share |